iSpecimen

Update in progress

ISPC (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryDiagnostics & Research

iSpecimen Inc. runs an online marketplace that connects life science researchers with hospitals, labs, and other providers of human biospecimens. The platform offers biofluids such as blood, plasma, serum, urine, saliva, sputum, nasopharyngeal samples, and CSF; solid tissues (fresh, fixed, frozen, FFPE blocks and slides); and hematopoietic/immune cells (bone marrow, cord blood, PBMCs). Customers include biopharma, IVD firms, and government or academic institutions. Founded 2009, based in Woburn, MA.

Company score

Sentiment: 0.23; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.00; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.02; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.01; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.12; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive